PAR 2.04% 24.0¢ paradigm biopharmaceuticals limited..

PAR General discussion, page-170

  1. 1,228 Posts.
    lightbulb Created with Sketch. 178

    Anyone elsestill looking for a possible CEO for PAR? Today’s livewire markets have an interview by Matthew Kidman with JohnMcBain which I found very interesting. I’m still thinking that having an American as CEO “COULD” have apositive impact for share price if / when moved to a USA listing, but I think that it will take more than justan American CEO to do the job of raising the share price to where it should beAND garner attention of our future product(s).

    From IVFpioneer to Afterpay investor: JohnMcBain’s incredible journey

    ……. heprofited enough to turn his hand to full-time investing when others mightchoose to retire. Instead he chooses to engage with entrepreneurs innovating insectors as diverse as biotechnology, digital agriculture and fintech.

    A string of brilliant stock selections, including amajor foray into Afterpay before it listed, has made John a prominent figure inAustralia'ssmall company environment.

    https://www.livewiremarkets.com/wires/from-ivf-pioneer-to-afterpay-investor-john-mcbain-s-incredible-journey


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
-0.005(2.04%)
Mkt cap ! $83.98M
Open High Low Value Volume
25.0¢ 25.5¢ 24.0¢ $202.2K 814.1K

Buyers (Bids)

No. Vol. Price($)
5 181098 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 118621 5
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.